Indolizidine and quinolizidine alkaloids.
Michael
J P
JP
Molecular Sciences Institute, School of Chemistry, University of the Witwatersrand, Wits, South Africa. jmichael@aurum.chem.wits.ac.za
D000470:Alkaloids / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D000663:Amphibians; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D001000:Ants / Q000737:chemistry; D001392:Azocines; D002384:Catalysis; D004926:Escherichia coli / Q000187:drug effects; D006900:Hydroxylation; D007212:Indolizines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D007313:Insecta / Q000737:chemistry; D029561:Lythraceae / Q000737:chemistry; D015394:Molecular Structure; D019906:Nuclear Magnetic Resonance, Biomolecular; D011161:Porifera / Q000737:chemistry; D011807:Quinolizines / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D013034:Sparteine / Q000138:chemical synthesis / Q000737:chemistry; D013237:Stereoisomerism; D013302:Streptomyces / Q000737:chemistry / Q000378:metabolism; D017026:Swainsonine / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000737:chemistry; D000093842:Matrines; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D000806:Angiotensin-Converting Enzyme Inhibitors; D001392:Azocines; D007212:Indolizines; D011807:Quinolizines; D013034:Sparteine; D017026:Swainsonine; D000093842:Matrines; C450779:porantheridine; C450780:septicine; C057484:ipalbidine; C015971:lupinine; D000093843:Quinolizidine Alkaloids; C009275:slaframine; C004712:cytisine; C046684:A 58365A